Opportunity Information: Apply for RFA MH 12 050
Apply for RFA MH 12 050
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Optimizing Fidelity of Empirically Supported Behavioral Treatments for Mental Disorders (R21/R33)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
- This funding opportunity was created on Mar 31, 2011 and posted on Mar 31, 2011.
- Applicants must submit their applications by Jun 20, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Independent school districts City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) State governments Small businesses Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign (non U.S.) components of U.S. Organizations are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Optimizing Fidelity of Empirically Supported Behavioral Treatments for Mental Disorders (R21/R33)" (Funding Opportunity Number RFA MH 12 050) is a National Institutes of Health (NIH) discretionary grant program focused on a practical implementation problem in mental health care: even when empirically supported behavioral treatments (ESBTs) are proven effective in controlled research, their real-world impact can drop when they are delivered in everyday community settings. The purpose of this FOA is to fund research that improves how faithfully (and competently) front line clinicians deliver ESBTs in routine practice, with the larger goal of improving patient outcomes by closing the gap between what works in trials and what happens in clinics, schools, and other community care environments.
A key theme of the announcement is "fidelity," meaning the degree to which a therapist delivers a treatment as it was designed and tested. The FOA treats fidelity as something that has specific, theory-derived components that can be defined, measured, and strengthened. It also recognizes a common bottleneck in implementation research: you cannot reliably improve fidelity if you cannot measure it well in the first place. For that reason, the program uses a two-stage, sequential funding structure (R21 followed by R33) to support projects that first build strong fidelity assessment methods and then use those methods to test interventions that actually improve and sustain fidelity among clinicians working in real-world settings.
In the first phase (the R21 exploratory/developmental phase), applicants are expected to develop and test methods for assessing fidelity components of ESBTs. This part is about measurement development and validation. Projects in this stage would typically identify the core elements of a specific ESBT, translate those elements into observable and rateable behaviors or decision points, and then design tools to measure whether and how well clinicians are delivering those elements. The FOA emphasizes that fidelity assessment must be valid and reliable, which generally implies demonstrating things like inter-rater reliability, sensitivity to differences in clinician performance, feasibility in community workflows, and a credible link between what is measured and the treatment theory (for example, measuring adherence to key cognitive restructuring steps in a CBT protocol rather than just counting session length or attendance). The R21 work is meant to produce an assessment approach that is strong enough to support the next phase.
In the second phase (the R33 phase), the focus shifts from measurement to action: developing and testing interventions that enhance and maintain clinician fidelity to an ESBT in community practice settings. In practical terms, this could include strategies such as improved training models, structured supervision methods, ongoing consultation, performance feedback systems based on fidelity ratings, decision supports, or other implementation supports designed to help clinicians deliver the treatment consistently over time. A major emphasis is not just short-term improvement after training, but sustained fidelity in the conditions that typically erode it in the field, such as high caseloads, staff turnover, competing demands, limited supervision resources, and organizational constraints. The R33 phase is where applicants would test whether the proposed fidelity-improvement approach works under real-world conditions, using the fidelity assessment methods developed in R21 as the measurement backbone.
The program sits in the health funding category and is tied to CFDA 93.242 (Mental Health Research Grants). It does not require cost sharing or matching funds, which lowers the barrier for many organizations that may not have discretionary funds to contribute. The estimated total funding listed is $1,500,000, and the award ceiling is $225,000, indicating relatively modest individual award sizes consistent with early-stage measurement development followed by a more focused implementation intervention test rather than a large multi-site clinical trial. The FOA was posted March 31, 2011, with an original and final closing date of June 20, 2011, and an archive date of July 21, 2011, meaning it is a past opportunity, but still useful as a model for understanding NIH priorities and the structure of phased implementation research.
Eligibility is broad and includes a wide range of organizations that could realistically conduct community-based mental health research. Eligible applicants include public and private institutions of higher education, nonprofits (including 501(c)(3) organizations), for-profit organizations (other than small businesses are explicitly listed, and small businesses are also eligible), state and local government entities (including city, county, township, special district governments), independent school districts, public housing authorities/Indian housing authorities, and multiple tribal entities (federally recognized tribal governments and other tribal organizations). The eligibility language also explicitly includes faith-based and community-based organizations, minority-serving institutions such as HBCUs and Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, regional organizations, U.S. territories or possessions, and eligible federal agencies. Foreign organizations (non-U.S. entities) are listed as eligible applicants, but the FOA also specifies that foreign (non-U.S.) components of U.S. organizations are not allowed, which is an important nuance for applicants with international operations or collaborations.
Overall, the opportunity is designed for research teams who can bridge clinical science and implementation realities: defining what "doing the treatment right" actually means for a specific ESBT, measuring it accurately without overwhelming community settings, and then testing practical, scalable methods to help clinicians reach and maintain that standard. The logic of the FOA is straightforward: strong fidelity measurement (R21) enables credible fidelity improvement strategies (R33), which in turn should increase the effectiveness of ESBTs as delivered in the real world. For the full announcement details, NIH provided the link: http://grants.nih.gov/grants/guide/rfa_files/RFA_MH_12_050.html, and technical access issues were directed to the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the focus of the "Optimizing Fidelity of Empirically Supported Behavioral Treatments for Mental Disorders (R21/R33)" opportunity?
This NIH discretionary grant opportunity (Funding Opportunity Number RFA MH 12 050) funds research aimed at improving how faithfully and competently front line clinicians deliver empirically supported behavioral treatments (ESBTs) in routine, real-world community settings. The goal is to reduce the drop in impact that can happen when treatments that work well in controlled research settings are delivered in everyday practice (clinics, schools, and other community care environments), ultimately improving patient outcomes.
What does "fidelity" mean in this FOA?
In this FOA, "fidelity" refers to the degree to which a therapist delivers a behavioral treatment as it was designed and tested. The announcement frames fidelity as having specific, theory-derived components that can be defined, measured, and strengthened (for example, adherence to key steps in a treatment protocol, delivered with competence).
Why does the FOA emphasize fidelity measurement before fidelity improvement?
The FOA highlights a common implementation bottleneck: it is difficult to reliably improve fidelity if it cannot be measured well. Because of that, the program uses a two-stage structure where the first stage (R21) focuses on building valid and reliable fidelity assessment methods, and the second stage (R33) uses those methods to test interventions designed to improve and sustain fidelity in routine practice.
How is the funding structured across the R21 and R33 phases?
The opportunity uses a sequential, two-stage structure: an R21 exploratory/developmental phase followed by an R33 phase. The R21 phase is intended for developing and testing fidelity assessment methods. The R33 phase is intended for developing and testing interventions that enhance and maintain clinician fidelity in community practice settings, using the R21-developed assessment methods as the measurement backbone.
What kinds of activities are expected in the R21 phase?
In the R21 phase, applicants are expected to develop and test methods for assessing fidelity components of ESBTs. Typical activities include identifying the core elements of a specific ESBT, translating those elements into observable and rateable clinician behaviors or decision points, and designing tools to measure whether and how well clinicians deliver those elements.
What does the FOA say about what makes a fidelity assessment method strong enough for this program?
The FOA emphasizes that fidelity assessment must be valid and reliable. Examples of what this implies include demonstrating inter-rater reliability, sensitivity to differences in clinician performance, feasibility within community workflows, and a credible link between what is being measured and the underlying treatment theory (for example, measuring adherence to key cognitive restructuring steps in a CBT protocol rather than only tracking session length or attendance).
What kinds of activities are expected in the R33 phase?
In the R33 phase, the focus shifts to developing and testing interventions that enhance and maintain clinician fidelity to an ESBT in community practice settings. The FOA describes practical strategies such as improved training models, structured supervision methods, ongoing consultation, performance feedback systems based on fidelity ratings, decision supports, and other implementation supports aimed at helping clinicians deliver the treatment consistently over time.
Does the FOA prioritize short-term fidelity gains or long-term sustainment?
The FOA places major emphasis on sustained fidelity, not only short-term improvement after training. It explicitly notes real-world conditions that can erode fidelity over time, such as high caseloads, staff turnover, competing demands, limited supervision resources, and organizational constraints.
What settings does the FOA consider "real-world" community practice environments?
The FOA describes routine practice settings such as clinics, schools, and other community care environments where ESBTs are delivered by front line clinicians under everyday operational constraints.
What is the broader problem this FOA is trying to solve?
The FOA targets the gap between what works in controlled clinical trials and what happens in day-to-day care. Even when ESBTs are proven effective in research, their impact can drop when implemented in community settings. This program supports research intended to close that gap by improving treatment delivery fidelity and, in turn, patient outcomes.
What is the CFDA number and funding category associated with this opportunity?
The opportunity is tied to CFDA 93.242 (Mental Health Research Grants) and sits within the health funding category.
Is cost sharing or matching required?
No. The opportunity states that cost sharing or matching funds are not required.
What is the estimated total funding and the award ceiling?
The estimated total funding listed is $1,500,000. The award ceiling is $225,000.
When was the FOA posted and what were the key dates?
The FOA was posted on March 31, 2011. The original and final closing date was June 20, 2011. The archive date was July 21, 2011.
Is this an active funding opportunity?
Based on the dates provided (final closing date June 20, 2011 and archive date July 21, 2011), this is a past opportunity rather than an active open solicitation. It may still be useful as a model for understanding NIH priorities and the phased approach to implementation research described in the announcement.
Who is eligible to apply?
Eligibility is broad and includes: public and private institutions of higher education; nonprofits (including 501(c)(3) organizations); for-profit organizations (including small businesses); state and local government entities (including city, county, township, and special district governments); independent school districts; public housing authorities/Indian housing authorities; tribal entities (federally recognized tribal governments and other tribal organizations); faith-based and community-based organizations; minority-serving institutions (including HBCUs and Hispanic-serving institutions); tribally controlled colleges and universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; regional organizations; U.S. territories or possessions; and eligible federal agencies.
Are foreign organizations eligible?
Yes. Foreign organizations (non-U.S. entities) are listed as eligible applicants.
Are foreign components of U.S. organizations allowed?
No. The FOA specifies that foreign (non-U.S.) components of U.S. organizations are not allowed. This is a key nuance for applicants with international operations or collaborations.
What types of research teams is this FOA designed for?
The FOA is designed for research teams that can bridge clinical science and implementation realities, including: defining what "doing the treatment right" means for a specific ESBT; measuring fidelity accurately without overwhelming community settings; and testing practical, scalable methods to help clinicians reach and maintain fidelity standards in routine practice.
Where can applicants find the full announcement?
The FOA indicates the full announcement details were available at: http://grants.nih.gov/grants/guide/rfa_files/RFA_MH_12_050.html
Who should be contacted for technical access issues related to the NIH posting?
The FOA directs technical access issues to the NIH Office of Extramural Research webmaster at: FBOWebmaster@OD.NIH.GOV
Browse more opportunities from the same category: Health
Next opportunity: Finding the Next Generation of Land Ethic Leaders
Previous opportunity: Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 12 050
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 12 050) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Angolan Systems for Health (SASH) Apply for RFA674 11 32 Funding Number: RFA674 11 32 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $33,000,000 |
| Support of NIAMS Program Project Grants (P01) Apply for PAR 11 188 Funding Number: PAR 11 188 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Dental Reimbursement Program Apply for HRSA 11 097 Funding Number: HRSA 11 097 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability Apply for CDC RFA CK11 0010101PPHF11 Funding Number: CDC RFA CK11 0010101PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,508,825 |
| Public Prevention Health Fund Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9020302PPHF11 Funding Number: CDC RFA DP09 9020302PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Integrating Multi Dimensional Data to Explore Mechanisms Underlying Mental Disorders (RO1) Apply for RFA MH 12 020 Funding Number: RFA MH 12 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 11 189 Funding Number: PAR 11 189 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Public Prevention Health Fund State Supplemental Funding for Healthy Communities, Tobacco Prevention and Control, Diabetes Prevention and Control, and Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9010201PPHF11 Funding Number: CDC RFA DP09 9010201PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 071 Funding Number: HRSA 11 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| State Implementation Planning Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 081 Funding Number: HRSA 11 081 Agency: Health Resources and Services Administration Category: Health Funding Amount: $75,000 |
| Control of NTD ENVISION Apply for RFA OAA 11 000007 Funding Number: RFA OAA 11 000007 Agency: Agency for International Development Category: Health Funding Amount: $250,000,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 12 002 Funding Number: RFA AA 12 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| Comprehensive Alcohol Research Centers (P60) Apply for RFA AA 12 003 Funding Number: RFA AA 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Emergency Countermeasure Dispensing Staffing Plan Apply for CDC RFA TP11 1102 Funding Number: CDC RFA TP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3) Apply for RFA 680 11 000001 Funding Number: RFA 680 11 000001 Agency: Benin USAID Cotonou Category: Health Funding Amount: $30,000,000 |
| NIMHD Resource Related Minority Health and Health Disparities Research (U24) Apply for RFA MD 11 005 Funding Number: RFA MD 11 005 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| REQUEST FOR COMMENTS South Africa Comprehensive Clinical HIV Related Service, Support and Capacity Development, in line with South African national, provincial and district policies, standards and implementation plans Apply for 674 11 0038 Funding Number: 674 11 0038 Agency: South Africa USAID Pretoria Category: Health Funding Amount: Case Dependent |
| Anchoring Metabolomic Changes to Phenotype (P20) Apply for RFA HL 12 009 Funding Number: RFA HL 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic Research in Calcific Aortic Valve Disease (R01) Apply for RFA HL 12 015 Funding Number: RFA HL 12 015 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pulmonary Vascular Right Ventricular Axis Research Program (R01) Apply for RFA HL 12 021 Funding Number: RFA HL 12 021 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 12 050", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.